Montgeron, Ile-de-France, France Funds with similar focus
| Fund Name | Location |
| B&Y Venture Capital Partners | - |
| Betafabrik | Germany, Köln, Nordrhein-Westfalen |
| Blue Shield Information Security Technology | - |
| Bozavida Ventures | - |
| Bridgescale Partners | California, Menlo Park, United States |
| Fairchild Capital Management | China, Hong Kong, Hong Kong Island |
| Greehey & Co. | San Antonio, Texas, United States |
| HH Investments VC | Central Region, Singapore, Singapore |
| Huoerguosi Jiubang Xinxi Jishu Youxian Gongsi | - |
| Leslie Ventures | California, Portola Valley, United States |
| MRV Communications | California, Chatsworth, United States |
| Pusu Capital | China, Guangdong, Shenzhen |
| Quadrise Canada Corporation | Alberta, Calgary, Canada |
| RBI Opportunities Fund | - |
| Silicon Laboratories | Austin, Texas, United States |
| STAGE Japan | Japan, Toshima |
| Tenshi Life Sciences | - |
| U.S. Department of Health & Human Services | District of Columbia, United States, Washington |
| Williams Advanced Engineering | Oxford, Oxfordshire, United Kingdom |
| Worldwide Wes | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
OncoDiag | $2M | 15 Mar 2021 | France, Auvergne-Rhône-Alpes, France |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
OncoDiag | $2M | 15 Mar 2021 | France, Auvergne-Rhône-Alpes, France |
